These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 7537361)

  • 21. Phosphorylation of cbl after stimulation of Nb2 cells with prolactin and its association with phosphatidylinositol 3-kinase.
    Hunter S; Koch BL; Anderson SM
    Mol Endocrinol; 1997 Aug; 11(9):1213-22. PubMed ID: 9259313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutant forms of growth factor-binding protein-2 reverse BCR-ABL-induced transformation.
    Gishizky ML; Cortez D; Pendergast AM
    Proc Natl Acad Sci U S A; 1995 Nov; 92(24):10889-93. PubMed ID: 7479904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a novel tyrosine phosphorylated 100-kDa protein that binds to SHP-2 and phosphatidylinositol 3'-kinase in myeloid cells.
    Carlberg K; Rohrschneider LR
    J Biol Chem; 1997 Jun; 272(25):15943-50. PubMed ID: 9188495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Shc binding to nerve growth factor receptor is mediated by the phosphotyrosine interaction domain.
    Dikic I; Batzer AG; Blaikie P; Obermeier A; Ullrich A; Schlessinger J; Margolis B
    J Biol Chem; 1995 Jun; 270(25):15125-9. PubMed ID: 7541035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins.
    Salcini AE; McGlade J; Pelicci G; Nicoletti I; Pawson T; Pelicci PG
    Oncogene; 1994 Oct; 9(10):2827-36. PubMed ID: 8084588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein tyrosine phosphatase 1B antagonizes signalling by oncoprotein tyrosine kinase p210 bcr-abl in vivo.
    LaMontagne KR; Flint AJ; Franza BR; Pandergast AM; Tonks NK
    Mol Cell Biol; 1998 May; 18(5):2965-75. PubMed ID: 9566916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of Shc with Grb2 regulates association of Grb2 with mSOS.
    Ravichandran KS; Lorenz U; Shoelson SE; Burakoff SJ
    Mol Cell Biol; 1995 Feb; 15(2):593-600. PubMed ID: 7529871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein.
    Pendergast AM; Quilliam LA; Cripe LD; Bassing CH; Dai Z; Li N; Batzer A; Rabun KM; Der CJ; Schlessinger J
    Cell; 1993 Oct; 75(1):175-85. PubMed ID: 8402896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Shc phosphorylation in myeloid cells is regulated by granulocyte macrophage colony-stimulating factor, interleukin-3, and steel factor and is constitutively increased by p210BCR/ABL.
    Matsuguchi T; Salgia R; Hallek M; Eder M; Druker B; Ernst TJ; Griffin JD
    J Biol Chem; 1994 Feb; 269(7):5016-21. PubMed ID: 7508932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B cell antigen receptor cross-linking induces tyrosine phosphorylation and membrane translocation of a multimeric Shc complex that is augmented by CD19 co-ligation.
    Lankester AC; van Schijndel GM; Rood PM; Verhoeven AJ; van Lier RA
    Eur J Immunol; 1994 Nov; 24(11):2818-25. PubMed ID: 7525306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The phosphatidylinositol polyphosphate 5-phosphatase SHIP1 associates with the dok1 phosphoprotein in bcr-Abl transformed cells.
    Dunant NM; Wisniewski D; Strife A; Clarkson B; Resh MD
    Cell Signal; 2000 May; 12(5):317-26. PubMed ID: 10822173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Yeast two-hybrid in vivo association of the Src kinase Lyn with the proto-oncogene product Cbl but not with the p85 subunit of PI 3-kinase.
    Dombrosky-Ferlan PM; Corey SJ
    Oncogene; 1997 May; 14(17):2019-24. PubMed ID: 9160881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transformation and pp60v-src autophosphorylation correlate with SHC-GRB2 complex formation in rat and chicken cells expressing host-range and kinase-active, transformation-defective alleles of v-src.
    Verderame MF; Guan JL; Woods Ignatoski KM
    Mol Biol Cell; 1995 Aug; 6(8):953-66. PubMed ID: 7579711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Src-family tyrosine kinases in activation of ERK-1 and p85/p110-phosphatidylinositol 3-kinase by G/CCKB receptors.
    Daulhac L; Kowalski-Chauvel A; Pradayrol L; Vaysse N; Seva C
    J Biol Chem; 1999 Jul; 274(29):20657-63. PubMed ID: 10400698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. P210 Bcr-Abl interacts with the interleukin 3 receptor beta(c) subunit and constitutively induces its tyrosine phosphorylation.
    Wilson-Rawls J; Xie S; Liu J; Laneuville P; Arlinghaus RB
    Cancer Res; 1996 Aug; 56(15):3426-30. PubMed ID: 8758906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p130CAS forms a signaling complex with the adapter protein CRKL in hematopoietic cells transformed by the BCR/ABL oncogene.
    Salgia R; Pisick E; Sattler M; Li JL; Uemura N; Wong WK; Burky SA; Hirai H; Chen LB; Griffin JD
    J Biol Chem; 1996 Oct; 271(41):25198-203. PubMed ID: 8810278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD16-mediated p21ras activation is associated with Shc and p36 tyrosine phosphorylation and their binding with Grb2 in human natural killer cells.
    Galandrini R; Palmieri G; Piccoli M; Frati L; Santoni A
    J Exp Med; 1996 Jan; 183(1):179-86. PubMed ID: 8551221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The SH2-containing adapter protein GRB10 interacts with BCR-ABL.
    Bai RY; Jahn T; Schrem S; Munzert G; Weidner KM; Wang JY; Duyster J
    Oncogene; 1998 Aug; 17(8):941-8. PubMed ID: 9747873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New role for Shc in activation of the phosphatidylinositol 3-kinase/Akt pathway.
    Gu H; Maeda H; Moon JJ; Lord JD; Yoakim M; Nelson BH; Neel BG
    Mol Cell Biol; 2000 Oct; 20(19):7109-20. PubMed ID: 10982827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective expression and constitutive phosphorylation of SHC proteins [corrected] in the CD34+ fraction of chronic myelogenous leukemias.
    Bonati A; Carlo-Stella C; Lunghi P; Albertini R; Pinelli S; Migliaccio E; Sammarelli G; Savoldo B; Tabilio A; Dall'Aglio PP; Pelicci PG
    Cancer Res; 2000 Feb; 60(3):728-32. PubMed ID: 10676660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.